Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus

Aims/Introduction:  Repaglinide is a short‐acting insulin secretagogue. We assessed the efficacy and safety of repaglinide in comparison with nateglinide in Japanese patients with type 2 diabetes previously treated with diet and exercise. Materials and Methods:  In this 16‐week randomized, multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamori, Ryuzo, Kaku, Kohei, Hanafusa, Toshiaki, Kashiwabara, Daisuke, Kageyama, Shigeru, Hotta, Nigishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014954/
https://www.ncbi.nlm.nih.gov/pubmed/24843581
http://dx.doi.org/10.1111/j.2040-1124.2011.00188.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014954/
https://www.ncbi.nlm.nih.gov/pubmed/24843581
http://dx.doi.org/10.1111/j.2040-1124.2011.00188.x

Ejemplares similares